Bicycle Therapeutics (BCYC) Total Liabilities (2018 - 2026)

Bicycle Therapeutics has reported Total Liabilities for 9 years, with the latest figure at $98.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 31.68% year-over-year to $98.1 million; the trailing twelve-month figure through Mar 2026 stood at $98.1 million (down 31.68% YoY), and the FY2025 full-year result was $107.6 million, down 34.3% from the prior year.
• Total Liabilities for Q1 2026 stood at $98.1 million, down from $107.6 million in the prior quarter.
• The five-year high for Total Liabilities was $234.1 million in Q2 2023, with the low at $98.1 million in Q1 2026.
• Historically, Total Liabilities has averaged $162.3 million across 5 years, with a median of $163.3 million in 2025.
• Annual changes were most pronounced in 2023 — Total Liabilities soared 74.56% — and 2025, when it plunged 34.3%.
• Bicycle Therapeutics' Total Liabilities stood at $139.8 million in 2022, then jumped by 60.49% to $224.4 million in 2023, then retreated by 27.01% to $163.8 million in 2024, then sank by 34.3% to $107.6 million in 2025, then retreated by 8.87% to $98.1 million in 2026.
• The last three Total Liabilities figures came in at $98.1 million (Q1 2026), $107.6 million (Q4 2025), and $145.5 million (Q3 2025), per Business Quant data.